Should I Buy BETA? BETA 2026 Analysis

Should You Buy BETA Technologies Inc (BETA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

19.240

1 Day change

-3.46%

52 Week Range

39.500

Analysis Updated At

2026/01/28

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now (starter long-term position). Despite a clearly bearish near-term chart, BETA is extremely oversold (RSI_6 ~16) while fundamentals/news flow show meaningful execution (FAA certification, initial deliveries, $3.5B backlog, very large cash balance) and Wall Street targets imply substantial upside (most recent targets around $37 vs ~$24). For a Beginner, long-term investor with $50k–$100k and no desire to wait for a perfect entry, the current oversold level offers an attractive “buy-now” spot, with the expectation of volatility and potential near-term downside toward the next support (~$22.91).

Technical Analysis

Trend/price action: Bearish trend remains intact (SMA_200 > SMA_20 > SMA_5) and MACD histogram is negative (-0.372) and expanding, signaling downside momentum is still present. Momentum/mean reversion: RSI_6 at ~16 is deeply oversold, which often precedes sharp bounces even within downtrends. Levels: The stock is trading around 24.08, below S1 (24.446), which suggests that prior support has been lost; next notable support is S2 ~22.91. Upside resistance begins around the pivot ~26.93, then ~29.42. Intellectia Proprietary Trading Signals: - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today. Interpretation: Technically this is not a “trend-following” buy; it is an oversold, catalyst-backed entry where near-term volatility is likely but risk/reward improves versus higher levels.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Put-call ratios near 0.5 (both OI and volume) indicate calls outweigh puts, generally a bullish/optimistic options posture.

Activity/positioning: Volume is elevated vs the 30-day average (~148%), and today’s open interest is also elevated vs average (~240%), suggesting heightened attention and positioning.

Volatility: IV is very high (30D IV ~87; IV percentile ~87.5; IV rank ~88), implying the options market is pricing large moves (both directions). This supports the view that sentiment is optimistic but the stock is likely to remain very volatile.

Technical Summary

Sell

Buy

Positive Catalysts

- Event-driven/News sentiment: Positive. The company reported quarterly revenue of $8.9M, described as nearly tripling YoY, driven by defense services and motor deliveries.
- Balance sheet catalyst: Ended the quarter with ~ $688M cash/equivalents, with an expected additional ~$1.1B from IPO proceeds (strong funding runway).
- Execution milestones: Completed initial customer deliveries, secured FAA certification, and reported a backlog of 891 aircraft (~$3.5B).
- Influential/institutional activity: Liberty Street Advisors acquired ~999,202 shares for ~$28.19M (a notable vote of confidence).
- Street support: Multiple Buy ratings with raised price targets (to ~$37).

Neutral/Negative Catalysts

- Profitability: Latest quarter shows very large losses (net income about -$451.8M; EPS -2.02), indicating the business is still far from sustained profitability.

Financial Performance

Latest quarter (2025/Q3): Revenue was ~$8.918M (news summary indicates nearly triple YoY), gross margin reported at ~69.26% (strong on a gross basis), but net income was deeply negative (~-$451.81M) with EPS of -2.02, underscoring that the company is in a heavy investment/scale-up phase. The key growth takeaway is accelerating revenue alongside major commercialization milestones, while losses remain the primary near-term fundamental drag.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst trend: Improving/constructive. Truist raised its price target to $37 (from $32) and reiterated Buy; BofA raised to $37 (from $35) and reiterated Buy after the first post-IPO earnings; Jefferies initiated at Hold with a $30 target. Wall Street pros: Clear commercialization milestones (certification/deliveries), large backlog, strong liquidity runway, and a pathway to durable revenue acceleration. Wall Street cons: Execution and adoption risk remains high in emerging electric aircraft markets; profitability is not near-term, and some analysts prefer to “wait for more progress” despite acknowledging de-risking versus peers.

7 Analyst Rating

Wall Street analysts forecast BETA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BETA is 36.17 USD with a low forecast of 30 USD and a high forecast of 42 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

1 Hold

0 Sell

Strong Buy

Current: 19.930

Low

Averages

36.17

High

Current: 19.930

Low

Averages

36.17

High

Truist

Richard Newitter

Buy

maintain

$32 -> $37

AI Analysis

2025-12-18

Reason

Truist

Richard Newitter

Price Target

$32 -> $37

AI Analysis

2025-12-18

maintain

Buy

Reason

Truist analyst Richard Newitter raised the firm's price target on Beta Bionics to $37 from $32 and keeps a Buy rating on the shares as part of a broader research note previewing 2026 for MedTech. The firm is more positive on the industry heading into next year given a more attractive relative sector valuation, though it also sees the possibility of it being a "source" vs. a destination of new healthcare investment flows, the analyst tells investors in a research note. Truist adds it prefers names with 2026 catalysts fueling durable revenue acceleration or out-of-favor near-term narratives.

BofA

Buy

maintain

$35 -> $37

2025-12-17

Reason

BofA

Price Target

$35 -> $37

2025-12-17

maintain

Buy

Reason

BofA raised the firm's price target on Beta Technologies to $37 from $35 and keeps a Buy rating on the shares after the company reported their first earnings since going public on November 3. The firm's raised target reflects increased revenue estimates from stronger results and partnerships, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BETA

Unlock Now

BETA Should I Buy

BETA Should I Buy

Should You Buy BETA Technologies Inc (BETA) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch